SOAT1 and kidney disorder: Treatment with avasimibe, a SOAT inhibitor, ameliorated TLT maturation and renal fibrosis in mice, suggesting that targeting SOAT1 may represent a novel therapeutic strategy for TLT-related kidney disease.